Encontrados 4 documentos, a visualizar página 1 de 1
Hyperbaric oxygen therapy as a complementary treatment for radiation proctitis:...
Alpuim Costa, D; Amaro, CE; Nunes, A; Cardoso, JS; Daniel, PM; Rosa, I; Branco, JVRadiotherapy (RT) is the backbone of multimodality treatment of more than half of cancer cases. Despite new modern RT techniques, late complications may occur such as radiation proctitis (RP). The natural history of RP is unpredictable. Minor symptoms may resolve spontaneously or require conservative treatment. On the other hand, for similar and uncomplicated clinical contexts, symptoms may persist and can even...
Hyperbaric oxygen therapy as a complementary treatment for radiation proctitis:...
Alpuim Costa, D; Amaro, CE; Nunes, A; Cardoso, JS; Daniel, PM; Rosa, I; Branco, JVRadiotherapy (RT) is the backbone of multimodality treatment of more than half of cancer cases. Despite new modern RT techniques, late complications may occur such as radiation proctitis (RP). The natural history of RP is unpredictable. Minor symptoms may resolve spontaneously or require conservative treatment. On the other hand, for similar and uncomplicated clinical contexts, symptoms may persist and can even...
Genetic variants identified by target next-generation sequencing in heart trans...
Martins, E; Sousa, A; Canedo, P; Leite, S; Pinto, R; Campelo, M; Amorim, S; Moura, B; Lopes, JM; Machado, JC; Cardoso, JSIntroduction and Objectives: Dilated cardiomyopathy (DCM) is a myocardial disease that can progress to a terminal stage, requiring heart transplantation. In this work we aim to contribute to knowledge of genetic variants in adult patients undergoing heart transplantation due to end-stage DCM, reporting the results obtained in our single-center tertiary hospital series using target next-generation sequencing (NG...
European experience on the practical use of levosimendan in patients with acute...
Follath, F; Franco, F; Cardoso, JSThe novel calcium sensitizer and ATP-dependent potassium channel opener levosimendan has been introduced for routine use in several European countries. Recent reports on clinical experience confirm the positive hemodynamic results and beneficial clinical effects described in the initial dose-finding and randomized comparative therapeutic trials in patients with severe low-output heart failure. In addition, stud...